ArticleAmerican journal of hematology2020

A phase I study of lenalidomide plus chemotherapy with idarubicin and cytarabine in patients with relapsed or refractory acute myeloid leukemia and high-risk myelodysplastic syndrome.

Caner Saygin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.